Top Markets
Coin of the day
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
株式のランク #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
株価
$0.6
最終同期: 2024-08-14
時価総額
$2.09M
変化(1日)
0.00%
変化(1年)
0.00%
SG
取引 ASLAN Pharmaceuticals Limited (ASLN)

カテゴリー

ASLAN Pharmaceuticals Limited(ASLN)のEPS
March 2024 時点のEPS TTM: $-7.92
ASLAN Pharmaceuticals Limitedの最新の財務報告と株価によると、同社の現在のEPS(TTM)は$-7.92です。2022年末には、EPSは$-14.72で、2021年のEPS$-10.64と増加でした。
ASLAN Pharmaceuticals LimitedのEPS履歴(2014から2026まで)
各年末時点のEPS
EPS 変化
2026 (TTM) $-7.92 -26.39%
2023 $-10.76 -26.90%
2022 $-14.72 38.35%
2021 $-10.64 14.16%
2020 $-9.32 -67.86%
2019 $-29.00 2.98%
2018 $-28.16 -13.94%
2017 $-32.72 372.83%
2016 $-6.92 -71.40%
2015 $-24.20 -79.00%
2014 $-115.24 0.00%
同様の企業または競合他社のEPS
企業 EPS EPSの差
$17.32 -318.69%
US
$27.74 -450.25%
NL
- -
CH
- -
KR
$13.70 -272.98%
BE